Capital Expenditures - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Capital Expenditures Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Capital Expenditures
-ÂŁ2.3B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
A
AstraZeneca PLC
NASDAQ:AZN
Capital Expenditures
-$4.1B
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
-3%
Indivior PLC
LSE:INDV
Capital Expenditures
-$52m
CAGR 3-Years
-14%
CAGR 5-Years
-24%
CAGR 10-Years
-6%
Hikma Pharmaceuticals PLC
LSE:HIK
Capital Expenditures
-$205m
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Allergy Therapeutics PLC
LSE:AGY
Capital Expenditures
-ÂŁ3.6m
CAGR 3-Years
-18%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
Dechra Pharmaceuticals PLC
LSE:DPH
Capital Expenditures
-ÂŁ30.3m
CAGR 3-Years
15%
CAGR 5-Years
-19%
CAGR 10-Years
-13%

See Also

What is GlaxoSmithKline PLC's Capital Expenditures?
Capital Expenditures
-2.3B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Capital Expenditures amounts to -2.3B GBP.

What is GlaxoSmithKline PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-3%

Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for GlaxoSmithKline PLC have been 2% over the past three years , -3% over the past five years , and -3% over the past ten years .

Back to Top